{"anticipatedPostingDate":"2026-11","denomUnitsSelected":"Participants","description":"Description:\n\nDMFS will be defined as the time between the date of randomization and the date of first distant metastasis or date of death (whatever the cause), whichever occurs first. For participants who remain alive and distant metastasis-free, DMFS will be censored on the date of last visit/contact with disease assessments. The percentage of participants with DMFS will be reported for all participants with PD-L1-positive tumors in both treatment arms.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 11 years","title":"Distant Metastases-free Survival (DMFS) for Participants With PD-L1-positive Tumor Expression","type":"SECONDARY"}